BackAvadel Pharmaceuticals plc Overview

Avadel Pharmaceuticals plc Current Cash

Latest current cash for AVDL: $80M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$79.81M
179.24% YoYΔ $51.23M vs prior year quarter

Peer average

Loading

Avadel Pharmaceuticals plc Current Cash History

Loading

Avadel Pharmaceuticals plc vs. peers: Current Cash Comparison

Loading

Avadel Pharmaceuticals plc Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Avadel Pharmaceuticals plc (AVDL) FAQ

As of the most recent data (September 2025), AVDL shows a current cash of $80M. That compares with $29M in the prior-year period — up 179.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AVDL's current cash is now $80M (was $29M) — a 179.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Avadel Pharmaceuticals plc is outperforming or lagging.

Tracking AVDL's current cash over time shows whether Avadel Pharmaceuticals plc is scaling, shrinking, or reshaping that part of the business. The current reading is $80M That compares with $29M in the prior-year period — up 179.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Avadel Pharmaceuticals plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $80M) with ownership activity and broader fundamentals.

Avadel Pharmaceuticals plc's current cash is $80M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.